NM_014467.3(SRPX2):c.1129A>G (p.Thr377Ala) AND Rolandic epilepsy, intellectual disability, and speech dyspraxia, X-linked

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Aug 20, 2020
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV001312244.7

Allele description [Variation Report for NM_014467.3(SRPX2):c.1129A>G (p.Thr377Ala)]

NM_014467.3(SRPX2):c.1129A>G (p.Thr377Ala)

Gene:

SRPX2:sushi repeat containing protein X-linked 2 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

Xq22.1

Genomic location:

Preferred name:

NM_014467.3(SRPX2):c.1129A>G (p.Thr377Ala)

HGVS:

NC_000023.11:g.100669281A>G
NG_021337.1:g.30116A>G
NM_014467.3:c.1129A>GMANE SELECT
NP_055282.1:p.Thr377Ala
NC_000023.10:g.99924278A>G

Protein change:

T377A

Links:

dbSNP: rs1355036934

NCBI 1000 Genomes Browser:

rs1355036934

Molecular consequence:

NM_014467.3:c.1129A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:: Rolandic epilepsy, intellectual disability, and speech dyspraxia, X-linked (RESDX)
Synonyms:: Rolandic epilepsy, impaired intellectual development, and speech dyspraxia
Identifiers:: MONDO: MONDO:0010388; MedGen: C1845070; OMIM: 300643

Recent activity

Clear Turn Off Turn On

10_20180412_Bin_METABAT_58_1
10_20180412_Bin_METABAT_58_1

biosample
3_20180529_Bin_20180529_Bin_53_sub_1
3_20180529_Bin_20180529_Bin_53_sub_1

biosample
10_20180426_Bin_METABAT_40_1
10_20180426_Bin_METABAT_40_1

biosample
0.2_20180508_Bin_31_sub
0.2_20180508_Bin_31_sub

biosample
0.2_20180412_Bin_139_sub_1
0.2_20180412_Bin_139_sub_1

biosample

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV001502680	Labcorp Genetics (formerly Invitae), Labcorp	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Uncertain significance (Aug 20, 2020)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV001502680

Labcorp Genetics (formerly Invitae), Labcorp

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Uncertain significance
(Aug 20, 2020)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001502680.4

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

Description

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with SRPX2-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change replaces threonine with alanine at codon 377 of the SRPX2 protein (p.Thr377Ala). The threonine residue is highly conserved and there is a small physicochemical difference between threonine and alanine.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Oct 13, 2024

ClinVar

Relating variation to medicine